News & Events about Catalent Inc.
Catalent, Inc. (NYSE: CTLT), the global leader in enabling pharma, biotech, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it will release financial results for the second quarter of fiscal year...
Avantor and Catalent Enter into Multi-Year Supply and Services Agreement Avantor and Catalent Enter into Multi-Year Supply and Services Agreement PR Newswire RADNOR, Pa. and SOMERSET, N.J., Jan. 9, 2023 RADNOR, Pa. and SOMERSET, N.J., Jan. 9, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a...
Catalent, Inc. (NYSE: CTLT), the global leader in enabling pharma, biotech, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that current board member and lead independent director J. Martin (Marty...
Shares of Catalent, Inc. (NYSE:CTLT Get Rating) have been assigned a consensus recommendation of Hold from the thirteen ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and ...
Ticker Report
2 months ago
Catalent, Inc. (NYSE:CTLT Get Rating) Equities research analysts at William Blair reduced their Q2 2023 earnings per share (EPS) estimates for Catalent in a report issued on Wednesday, November 2nd. William Blair analyst M. Smock now forecasts that the company will earn $0.53 per ...